Companies in the life sciences and health information technology industry face unique data privacy and security concerns based on the highly sensitive personal health information that they handle. In our continued coverage of a recent health sector data privacy and security webinar, WilmerHale partners Barry Hurewitz and Jonathan Cedarbaum address HIPAA’s nuances, including requirements for business associates and its applicability in medical research. They also highlight the latest regulatory guidance regarding medical and mobile devices, and move beyond HIPAA to examine current state and international regulations. In part one, Hurewitz discussed security issues specific to life science and health information technology companies and provided a federal regulatory overview. See also “Steps to Take Following a Healthcare Data Breach” (Apr. 22, 2015).